FilingIndex
10-KThe Record

Avalo Therapeutics, Inc. files 10-K

Filed Mar 8, 2021 · 5y ago · Accession 0001628280-21-004162

Plain English

Annual report — full-year financials, business overview, and risk factors.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Ticker
AVTX
CIK
1534120
Form type
10-K
Filing date
Mar 8, 2021
Report date
Dec 31, 2020
Document
cerc-20201231.htm
Size
11.7 MB